ENYO Pharma has developed a wholly innovative drug discovery engine based on a virus bio-mimetism approach allowing the discovery of first-in-class drug candidates with a good safety profile.
The approach is based on the construction of 3 evolutive and complementary tools:
1. An exhaustive knowledge base gathering all known virus-human protein-protein interactions mapped in details collected from more than 10 years of expert manual curation. This knowledge base is integrated into a bioinformatics platform dedidacted to drug discovery.
2. A library of bioactive peptides mimicking the viral mechanisms to modulate host cell functions
3. A library of small chemical molecules designed via 3D modelling from viral peptidic hit structures which are able to target the host proteins